Want to see JP:4531 full AI Analyst Report?
4531 Stock Chart & Stats
¥317.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥317.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥260.00 - ¥640.00
Previous CloseN/A
Volume43.40K
Average Volume (3M)39.67K
Market Cap
¥8.05B
Enterprise Value¥13.05B
Total Cash (Recent Filing)¥885.00M
Total Debt (Recent Filing)¥6.71B
Price to Earnings (P/E)24.3
Beta1.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet StrengthA persistent equity base with moderate leverage provides structural financial stability and borrowing capacity. This supports capital spending, dividends and cushions cyclicality, giving the company durable financial flexibility over the next several months despite earnings swings.
Free Cash Flow ReboundA material FCF turnaround in 2026 strengthens near-term liquidity and funding ability for capex, working capital and shareholder distributions. While prior years were weak, sustained positive cash flow improves resilience and reduces reliance on external financing.
Multi-year Revenue And ROE ImprovementConsistent top-line growth through 2025 alongside improving ROE indicates underlying demand and better capital efficiency. These structural trends support medium-term profitability potential if management sustains operational discipline and cost controls.
Bears Say
Earnings Step-downA sharp decline in net income materially reduces operating cushion and signals margin pressure or higher costs. That magnitude of earnings volatility impairs planning, limits reinvestment capacity, and increases sensitivity to demand or input-cost shocks over the medium term.
Inconsistent Cash GenerationMulti-year negative FCF before the 2026 rebound shows a structural weakness in converting profits to cash. Persistent cash volatility can force external financing, constrain capex or dividend policy, and weaken resilience to further earnings setbacks.
Elevated Debt LevelsAn increase in total debt that remains elevated reduces financial flexibility, especially amid the 2026 earnings decline. Higher leverage raises refinancing and interest-rate vulnerability and limits the company's ability to invest or respond to prolonged profitability weakness.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
Yuki Gosei Kogyo Co., Ltd. lowest stock price was ¥260.00 and its highest was ¥640.00 in the past 12 months.
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
Yuki Gosei Kogyo Co., Ltd.’s market cap is ¥8.05B.
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
According to Wall Street analysts Yuki Gosei Kogyo Co., Ltd.’s price is currently Overvalued.
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
Yuki Gosei Kogyo Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.97%. See more information on Yuki Gosei Kogyo Co., Ltd. dividends here
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
Yuki Gosei Kogyo Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
Yuki Gosei Kogyo Co., Ltd. has 21,974,000 shares outstanding.
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4531
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for industrial and agricultural applications. Key offerings include glycine and its derivatives, nicotinamide, isoniazid, various drug intermediates, and cosmetic raw materials. The company also provides a range of specialized compounds, such as those based on amino acids, pyridine, piperidine, and silicon, alongside biological products like DNA, nucleosides, protamine, and active pharmaceutical ingredients (APIs). Furthermore, they offer contract manufacturing services for pharmaceutical and chemical products. Established in 1947, Yuki Gosei Kogyo Co., Ltd. is headquartered in Tokyo, Japan.
Technical Analysis
NANKAI CHEMICAL COMPANY LIMITED
―
Nippon Soda Co., Ltd.
―
Toho Acetylene Co., Ltd.
―
Daito Chemix Corporation
―
Toyo Gosei Co., Ltd.
―